| Author/Editor | Liberman, Alon; Drobnič Radobuljac, Maja | |
| Title | Diabetes technology and the human factor | |
| Type | članek | |
| Vol. and No. | Letnik 19, št. suppl. S1 | |
| Publication year | 2017 | |
| Volume | str. S-120-S-127 | |
| ISSN | 1520-9156 - Diabetes technology & therapeutics | |
| Language | eng | |
| Abstract | Introduction Diabetes is one of the most prevalent chronic diseases in the world and the number of people with diabetes has steadily risen over the last decades. According to the 2014 World Health Organization (WHO) estimation, globally, 422 million adults aged over 18 years were living with diabetes of which type 1 diabetes (T1D) accounts for between 5% and 10% (1). Significant development achieved in the past few decades in diabetes technologies has made diabetes technological devices such as continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) an important component of diabetes treatment. Unfortunately, there is a significant lack of congruence between the worldwide prevalence of diabetes and the prevalence of diabetes technologies utilization. Although insulin pumps have been used for more than 35 years, the actual number of patients using insulin pumps in the United States is difficult to ascertain, but has been reported to range from 350,000 to 515,000 in 2008 (2). The prevalence of CSII use in the SWEET (Better control in Paediatric and Adolescent diabeteS: Working to crEate CEnTers of Reference) registry, including 16,570 children with T1D, was recently reported to be 44.4% (3). The number of patients using CGM is even lower. The scientific field of Human factor utilizes information from a variety of disciplines including (for example) psychology, education, engineering, and design, focusing on the human being and their interaction with products, technology, and environments both at the workplace and during other daily activities, in order to better understand the interaction between human and technological products. This infor- mation can increase our knowledge and bridge the gap between the increasing number of patients with diabetes and the use of diabetes technologies. In the present article selected studies that were published between July 2015 and June 2016 concerning these issues are reviewed and discussed. | |
| Keywords | diabetes glukoza insulin diabetes glucose inzulin |